Application 079153
- Type
- ANDA
- Sponsor
- TORRENT PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 25MG | No | No |
| 002 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 50MG | No | No |
| 003 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 100MG | No | No |
| 004 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079153-001 | TOPIRAMATE | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-002 | TOPIRAMATE | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-003 | TOPIRAMATE | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-004 | TOPIRAMATE | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A079153-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-004 | AB | 1 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-004 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-004 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 5424d59e-74f1-4c3c-b737-79e9776e0b60 | 2026-03-23 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Camber Pharmaceuticals, Inc. | dbc52b16-b93d-4d83-942b-485c502db1fa | 2026-03-16 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 7bc4ec7a-9b83-4842-9057-e1a804b2596d | 2026-03-13 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 035bf713-1642-4215-83ec-0ed07c29f92c | 2026-03-13 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| Topamax | TOPIRAMATE | Janssen Pharmaceuticals, Inc. | 21628112-0c47-11df-95b3-498d55d89593 | 2026-03-12 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | C | 164cb1f7-1a41-675f-e063-6294a90ae0dd | 2026-03-05 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Advanced Rx of Tennessee, LLC | 4b1d3130-cf3c-d7da-e063-6294a90a6079 | 2026-02-18 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 7f1e4475-6326-47a3-a317-b04b74b7c109 | 2026-02-02 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 55e71f43-1cd5-4efc-9641-fda0a09c30f0 | 2026-02-02 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Dr. Reddys Laboratories Inc. | f07d81bc-5090-fbc5-2945-557cf002849c | 2026-02-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals Inc. | 68b22d22-c2d3-4e90-b302-56f7cb731427 | 2026-01-28 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | AvKARE | 25b377f7-ea89-fb56-e063-6394a90a239d | 2026-01-19 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | afd4c2b9-b80c-b43a-e053-2995a90ac923 | 2026-01-01 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ca45d478-7214-5bc7-e053-2995a90aa601 | 2026-01-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ae63e0e2-ceb1-4cc7-88fa-92cfa4516960 | 2026-01-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | f3321dc5-0fb7-0d12-e053-2a95a90a9694 | 2026-01-01 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | ffd7be08-050e-dfcb-e053-6394a90ad286 | 2026-01-01 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Ascend Laboratories, LLC | cb966bcb-3af7-4dbe-b540-58d473b891e5 | 2025-12-18 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 1f327383-beb3-4d15-add6-5f1c749f2b3f | 2025-11-18 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Eprontia | TOPIRAMATE | Azurity Pharmaceuticals, Inc. | e2a4df59-fead-4a01-9021-9eda02c48010 | 2025-11-13 | Warnings, Adverse reactions | TOPIRAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 43063-094 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-094 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-538 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-538 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 52959-441 | TOPIRAMATE | topiramate | H.J. Harkins Company, Inc. | ANDA | Current |
| 52959-994 | TOPIRAMATE | topiramate | H.J. Harkins Company, Inc. | ANDA | Current |
| 61919-185 | TOPIRAMATE | topiramate tablet | DIRECT RX | ANDA | Current |
| 61919-825 | TOPIRAMATE | TOPIRAMATE | DIRECT RX | ANDA | Current |
| 61919-825 | TOPIRAMATE | TOPIRAMATE | DIRECT RX | ANDA | Current |
| 68788-9730 | TOPIRAMATE | topiramate | Preferred Pharmaceuticals | ANDA | Current |